Clinical Trial Update: Transarterial Chemoembolization in Combination With Nivolumab Performed for Intermediate Stage Hepatocellular Carcinoma [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating transarterial chemoembolization combined with nivolumab for intermediate-stage hepatocellular carcinoma has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma
• Liver Cancer

Drugs mentioned

• Transarterial chemoembolization (chemotherapy with embolization (various agents))
• nivolumab (nivolumab)

Snippet

Sponsor: AIO-Studien-gGmbH | Conditions: Carcinoma, Hepatocellular, Hepatic Carcinoma | Phase 2 | Status: COMPLETED